Carmen E. Pyragius

501 total citations
10 papers, 393 citations indexed

About

Carmen E. Pyragius is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Carmen E. Pyragius has authored 10 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Genetics and 3 papers in Cancer Research. Recurrent topics in Carmen E. Pyragius's work include Virus-based gene therapy research (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Neurogenetic and Muscular Disorders Research (2 papers). Carmen E. Pyragius is often cited by papers focused on Virus-based gene therapy research (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Neurogenetic and Muscular Disorders Research (2 papers). Carmen E. Pyragius collaborates with scholars based in Australia. Carmen E. Pyragius's co-authors include Carmela Ricciardelli, Martin K. Oehler, Noor A. Lokman, Miranda P. Ween, Peter Hoffmann, Andrew Ruszkiewicz, A. MacPherson, Maria Fuller, Alison S. F. Elder and Sharon Byers and has published in prestigious journals such as International Journal of Molecular Sciences, Cancer Letters and Oncotarget.

In The Last Decade

Carmen E. Pyragius

10 papers receiving 392 citations

Peers

Carmen E. Pyragius
Giuseppina Claps United States
Verónica Calvo United States
Allison Goldberg United States
Yangxin Fu Canada
Hye‐Kyung Jeon South Korea
Carmen E. Pyragius
Citations per year, relative to Carmen E. Pyragius Carmen E. Pyragius (= 1×) peers Ilenia Agliarulo

Countries citing papers authored by Carmen E. Pyragius

Since Specialization
Citations

This map shows the geographic impact of Carmen E. Pyragius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen E. Pyragius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen E. Pyragius more than expected).

Fields of papers citing papers by Carmen E. Pyragius

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen E. Pyragius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen E. Pyragius. The network helps show where Carmen E. Pyragius may publish in the future.

Co-authorship network of co-authors of Carmen E. Pyragius

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen E. Pyragius. A scholar is included among the top collaborators of Carmen E. Pyragius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen E. Pyragius. Carmen E. Pyragius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ricciardelli, Carmela, Noor A. Lokman, Wendy M. Bonner, et al.. (2018). Novel ex vivo ovarian cancer tissue explant assay for prediction of chemosensitivity and response to novel therapeutics. Cancer Letters. 421. 51–58. 37 indexed citations
2.
Jiang, Zhirui, Ainslie L.K. Derrick‐Roberts, Matilda R. Jackson, et al.. (2018). Delayed development of ossification centers in the tibia of prenatal and early postnatal MPS VII mice. Molecular Genetics and Metabolism. 124(2). 135–142. 13 indexed citations
3.
Ricciardelli, Carmela, Noor A. Lokman, Carmen E. Pyragius, et al.. (2017). Keratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance. Oncotarget. 8(11). 17819–17832. 45 indexed citations
4.
Derrick‐Roberts, Ainslie L.K., et al.. (2016). Reversal of established bone pathology in MPS VII mice following lentiviral-mediated gene therapy. Molecular Genetics and Metabolism. 119(3). 249–257. 16 indexed citations
5.
Lokman, Noor A., Carmen E. Pyragius, Andrew Ruszkiewicz, Martin K. Oehler, & Carmela Ricciardelli. (2016). Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome. Translational research. 171. 83–95.e2. 39 indexed citations
6.
Ricciardelli, Carmela, Noor A. Lokman, Miranda P. Ween, et al.. (2015). Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation. Clinical & Experimental Metastasis. 32(5). 441–455. 58 indexed citations
7.
Derrick‐Roberts, Ainslie L.K., Carmen E. Pyragius, Xenia Kaidonis, et al.. (2014). Lentiviral-Mediated Gene Therapy Results in Sustained Expression of β-Glucuronidase for up to 12 Months in the Gus mps/mps and up to 18 Months in the Gus tm(L175F)Sly Mouse Models of Mucopolysaccharidosis Type VII. Human Gene Therapy. 25(9). 798–810. 19 indexed citations
8.
Ricciardelli, Carmela, et al.. (2013). Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer. BMC Cancer. 13(1). 476–476. 72 indexed citations
9.
Lokman, Noor A., Alison S. F. Elder, Miranda P. Ween, et al.. (2013). Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis. Oncotarget. 4(8). 1199–1211. 55 indexed citations
10.
Pyragius, Carmen E., Maria Fuller, Carmela Ricciardelli, & Martin K. Oehler. (2013). Aberrant Lipid Metabolism: An Emerging Diagnostic and Therapeutic Target in Ovarian Cancer. International Journal of Molecular Sciences. 14(4). 7742–7756. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026